Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A

BSX.PRA

Market cap $973M

BSX.PRA Hedge Fund Activity: Q4 2020 in Review

7 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q4 2020, worth a combined $69.6M — down 94% from $1.08B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of BSX.PRA and 1 opened new positions — a net loss of 36 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Russell Investments Group, opening a new position worth an estimated $1.15M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $214M sold.

• 7 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q4 2020, down from 43 in Q3 2020.
• Funds reported $69.6M of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q4 2020, down 94% quarter-over-quarter.
• 1 fund opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q4 2020 and 37 closed out, a net change of -36 holders.
• The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q4 2020 was Russell Investments Group, an estimated $1.15M added.
• The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q4 2020 was T. Rowe Price Associates, an estimated $214M sold.

Based on aggregated 13F filings for Q4 2020.